SCHEMBL6253573

SCHEMBL6253573

Cc1cccc(C(=O)n2c(C)cc3cc(N)ccc32)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 2/20 0.41
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
TUBB1 Q9H4B7 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
CHEK1 O14757 1/20 0.37
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
CSNK1A1 P48729 1/20 0.37
GSK3A P49840 1/20 0.37
LIMK1 P53667 1/20 0.37
IKBKE Q14164 1/20 0.37
MAPK14 Q16539 1/20 0.37
TAOK1 Q7L7X3 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479624 0.86 BRPF1 (0.43) BRPF1HCRTR1HCRTR2AKR1C3AKR1C2
SCHEMBL6480163 0.78 AKR1C3 (0.44) BRPF1AKR1C3AKR1C2TUBB1ALDH1A1
SCHEMBL6489065 0.78 AKR1C3 (0.39) BRPF1HCRTR1HCRTR2AKR1C3AKR1C2
SCHEMBL6490788 0.76 TUBB1 (0.50) BRPF1HCRTR1HCRTR2AKR1C3AKR1C2
SCHEMBL6749324 0.76 BRPF1 (0.46) BRPF1AKR1C3AKR1C2TUBB1ALDH1A1
SCHEMBL6494742 0.74 AKR1C3 (0.40) AKR1C3AKR1C2NPC1RAB9APDE2A
SCHEMBL6229626 0.73 AKR1C3 (0.50) BRPF1AKR1C3AKR1C2TUBB1ALDH1A1
SCHEMBL1617658 0.73 BRPF1 (0.43) BRPF1AKR1C3AKR1C2TUBB1ALDH1A1
SCHEMBL5436506 0.69 NR1H2 (0.44) BRPF1AKR1C3AKR1C2TUBB1CHEK1
SCHEMBL5107559 0.69 P2RX4 (0.41) BRPF1AKR1C3AKR1C2TUBB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed